ReviewFrontiers in pediatrics2026
Advances in temporizing treatment strategies and associated complications for posthemorrhagic hydrocephalus in preterm infants.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posthemorrhagic hydrocephalus (PHH) is a severe complication of intraventricular hemorrhage in preterm infants. It can cause varying degrees of brain injury, neurological impairment, and even death. The pathogenesis of PHH is complex, and several temporizing treatment strategies are currently available. However, these approaches differ in their associated complications and long-term outcomes, and no consensus has been reached regarding the optimal temporizing intervention. This review summarizes the procedural characteristics, complications, and prognostic outcomes of current temporizing treatments for PHH. It also discusses the major challenges, ongoing controversies, and recent advances in PHH management, with the aim of informing clinical decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.